thermogenesis.com - Utang jangka cendhak perusahaan THMO

ThermoGenesis (THMO) produces automated biomaterial logistics systems, enabling research centers to maintain high profitability. This daily price chart reflects a current level of 0.00. The company's revenues rely on the sale of consumable kits for blood and stem cell processing. However, the slow adoption of new technologies is causing a liquidity shortage and the gradual depletion of existing cash reserves.

This indicator captures the total liabilities of ThermoGenesis (THMO) maturing within one year, allowing for an assessment of current liquidity and debt load. When analyzing this short-term debt chart, investors should correlate debt dynamics with operating income, taking into account the company's expenditures on implementing green ESG standards and modernizing diagnostic equipment production to reduce plastic waste.